4th April 2019
Recently, (24 March 2019), the FDA have started to scrutinise the safety of breast implants, which brings into focus the importance of post-marketing surveillance in patient […]
4th April 2019
EU referral procedures for safety reasons: Just started – review on screening patients before treatment with fluorouracil, capecitabine, tegafur and flucytosine. The review to examine existing […]
21st March 2019
TB is the world’s deadliest infectious killer. The disease is preventable and curable. Globally the TB mortality rate has reduced by 42% since 2000 (saving an […]